To explore the curative effects of Chuanzhi Tongluo capsule combined with rosuvastatin on patients with acute cerebral infarction with normal blood lipid.Methods:A total of 80 patients with acute cerebral infarction(normal blood lipid）in Fuyang People's Hospital from December 2017 to December 2018 were randomly divided into 2 groups，with 40 cases in each group.The observation group was treated with Chuanzhi Tongluo capsule and rosuvastatin，while the control group was treated with rosuvastatin.According to the neurologic impairment score，the curative effect standard was established，and the therapeutic effects of the 2 groups were compared.The hypersensitivity C-protein level before and after treatment was compared.T-test and Chi-square test were used to measure the treatment effect between the 2 groups.Results:The neurological deficit scores of the 2 groups after treatment were significantly lower than those before treatment(P<0.05).The differences between the 2 groups after treatment were statistically significant(P<0.05).The level of high-sensitivity C-reactive protein in the observation group after treatment was significantly lower than that in the control group(P<0.05).The total effective rate was 97.5% in the observation group and 82.5% in the control group.The difference between the 2 groups was statistically significant(P<0.05).There were no obvious adverse reactions in the 2 groups.Conclusion:The curative effects of Chuanzhi Tongluo capsule combined with rosuvastatin on acute cerebral infarction with normal blood lipid is better than that of rosuvastatin，which is clinically worthy of application.